Results 131 to 140 of about 2,895 (208)

Expert Panel Appraisal of the Treatment of Chronic Kidney Disease-Related Mineral and Bone Disorders (CKD-MBD): an Opinion-Based Approach [PDF]

, 2009
Adragão, T, Ferreira, A, Frazão, J, Ponce, P, Vinhas, J   +4 more
core  

Assessing the real-world drug safety of sevelamer for hyperphosphatemia: Insights from a comprehensive analysis of the FDA adverse event reporting system (FAERS) database. [PDF]

Medicine (Baltimore)
Shao X, Yang H, Tan C, Liu J, Zhou L.
europepmc   +1 more source

Effects of Sucroferric Oxyhydroxide Compared to Lanthanum Carbonate and Sevelamer Carbonate on Phosphate Homeostasis and Vascular Calcifications in a Rat Model of Chronic Kidney Failure. [PDF]

Biomed Res Int, 2015
Phan O, Maillard M, Malluche HH, Stehle JC, Funk F, Burnier M.   +5 more
europepmc   +1 more source

Emerging treatments and current strategies for mineral, vascular, and bone disorders in chronic kidney disease. [PDF]

World J Nephrol
Ilkun O, Jazayeri F, Kazory A.
europepmc   +1 more source

Cost Effectiveness of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in the Treatment of Hyperphosphataemia in Patients Receiving Dialysis, from the Perspective of the National Health Service in Scotland. [PDF]

Pharmacoeconomics, 2015
Gutzwiller FS, Pfeil AM, Ademi Z, Blank PR, Braunhofer PG, Szucs TD, Schwenkglenks M.   +6 more
europepmc   +1 more source

Use of ultrasound to assess the response to therapy for secondary hyperparathyroidism. [PDF]

, 2011
E, Colombini, G, Barsotti., MEOLA, Mario, PETRUCCI, Ilaria   +3 more
core   +1 more source

Evanescent extraosseous calcifications in low turnover bone: management and outcomes: a case report. [PDF]

Front Nephrol
Hernandez-Pérez M, Enos D.
europepmc   +1 more source

Efficacy and Safety of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in Chinese Dialysis Patients with Hyperphosphataemia: A Randomised, Open-Label, Multicentre, 12-Week Phase III Study.

Nephron
Liu J, Zuo L, Walpen S, Bernard L, Marty M, Enoiu M.   +5 more
europepmc   +1 more source

Parathyroidectomy in the treatment of uremic tumoral calcinosis: a 9-year case report and meta-analysis. [PDF]

BMC Nephrol
Huang H, Lu J, Lin J, Huang P, Ma J, Huang T, Qin H, Mo Y, Wang J, Qin C.   +9 more
europepmc   +1 more source

Risk factors for drug-related gastrointestinal ulcer:a retrospective pharmacovigilance study. [PDF]

Front Pharmacol
Jiang S, Wang M, Ren X, Jiang Z, Zhu Q, Dai S, Li J, Zhao Z, Han L.   +8 more
europepmc   +1 more source